Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-07-21
2008-12-16
Saoud, Christine J (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S350000
Reexamination Certificate
active
07465707
ABSTRACT:
The present invention relates to a novel protein, TR10, which is a member of the tumor necrosis factor (TNF) receptor superfamily and the TRAIL receptor subfamily. In particular, isolated nucleic acid molecules are provided encoding the human TR10 protein. TR10 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of TR10 activity.
REFERENCES:
patent: 5330910 (1994-07-01), Young et al.
patent: 5705379 (1998-01-01), Wilson et al.
patent: 6313269 (2001-11-01), Deen et al.
patent: 6342369 (2002-01-01), Ashkenazi et al.
patent: WO 98/32856 (1997-07-01), None
patent: WO 98/54202 (1998-12-01), None
patent: WO 99/03992 (1999-01-01), None
patent: WO 99/07850 (1999-02-01), None
patent: WO 99/10484 (1999-03-01), None
patent: WO 00/08155 (2000-02-01), None
patent: WO 00/34335 (2000-06-01), None
patent: WO 00/73321 (2000-12-01), None
patent: WO 00/77037 (2000-12-01), None
patent: WO 01/40466 (2001-06-01), None
Minami et al., Cellular Immunology, vol. 243, 2006, pp. 41-47.
Herbeubal et al., BLOOD, vol., 105, 2005, pp. 2458-2464.
Katsikis et al., Journal of Experimental Medicine, vol. 186, No. 8, Oct. 1997, pp. 1365-1372.
Ethell et al. (2003). Journal of Clinical Immunology. 23(5):363-370.
Gomes et al. (2003). Journal of Neuroimmunology. 135:126-134.
Peng, S.L. (2006). Rheumatology. 45:26-30.
Roos et al. (2006). Trends in Molecular Medicine. 12(9):440-450.
Norbury et al. (2004). Oncogene. 23:2797-2808.
Mercer et al. (2007). Mutation Research. 621-75-86.
Adams et al., Nature, 377:3-17 (1995).
Database SPTREMBL—17, Accession No. Q22385 (Nov. 1, 1996).
Database PIT—71, Van Patten et al., Accession No. A40962 (Mar. 20, 1992).
Database PIR—71, Scarpetta et al., Accession No. B46707 (Sep. 21, 1993).
Degli-Eposti et al., Journal of Experimental Medicine, 186(7):1165-1170 (1997).
Degli-Esposti et al., Immunity, 7:813-820 (1997).
GenBank Accession No. AA150849 (May 19, 1997).
GenBank Accession No. AA345927 (Apr. 21, 1997).
GenBank Accession No. AA374242 (Apr. 21, 1997).
GenBank Accession No. AA568830 (Aug. 22, 1997).
GenBank Accession No. AA705297 (Dec. 24, 1997).
GenBank Accession No. B32806 (Oct. 17, 1997).
GenBank Accession No. H71094 (Oct. 26, 1995).
GenBank Accession No. H71883 (Oct. 26, 1995).
GenBank Accession No. R00173 (Mar. 31, 1995).
GenBank Accession No. R16532 (Apr. 14, 1995).
GenBank Accession No. R16589 (Apr. 14, 1995).
GenBank Accession No. T66967 (Mar. 7, 1995).
GenBank Accession No. T66968 (Mar. 7, 1995).
GenBank Accession No. T71406 (Mar. 15, 1995).
GenBank Accession No. W52137 (Oct. 11, 1996).
Kornblau et al. Expert Opinion on Investigational Drugs 8(12):2027-57 (1999).
Marsters et al., Current Biology, 7(12):1003-1006 (1997).
Meng et al., Molecular Therapy, 1(2):130-144 (2000).
Pan et al., FEBS Lett., 424:41-45 (1998).
Pan et al., Science, 276:111-113 (1997).
Pan et al., Science, 277:815-818 (1997).
Sheridan et al., Science, 277:818-821 (1997).
Walczak et al., The EMBO Journal, 16(17):5386-5397 (1997).
International Search Report mailed Oct. 21, 1998, in connection with corresponding PCT Application No. PCT/US98/10981, filed May 29, 1998.
Supplementary Partial European Search Report mailed Nov. 25, 2002, in connection with related European Application No. 98925009.7, filed May, 1998.
Supplementary European Search Report mailed Jan. 22, 2004, in connection with related European Application No. 00936337, filed May 26, 2000.
Ni Jian
Rosen Craig A.
Human Genome Sciences Inc.
Lockard Jon M
Saoud Christine J
LandOfFree
Methods of treatment with TR10 polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treatment with TR10 polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treatment with TR10 polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4025199